EverSource Wealth Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.9K Buy
5,889
+232
+4% +$1.54K ﹤0.01% 1781
2026
Q1
$30.8K Buy
5,657
+4,945
+695% +$27.7K ﹤0.01% 2231
2025
Q4
$4.98K Buy
712
+111
+18% +$869 ﹤0.01% 3120
2025
Q3
$4.65K Buy
601
+504
+520% +$3.93K ﹤0.01% 3192
2025
Q2
$845 Sell
97
-69
-42% -$500 ﹤0.01% 3772
2025
Q1
$1.32K Sell
166
-67
-29% -$678 ﹤0.01% 3112
2024
Q4
$2.12K Buy
233
+67
+40% +$647 ﹤0.01% 2691
2024
Q3
$1.52K Buy
166
+158
+1,975% +$1.31K ﹤0.01% 2617
2024
Q2
$75 Sell
8
-154
-95% -$1.88K ﹤0.01% 3006
2024
Q1
$2.07K Sell
162
-212
-57% -$3.85K ﹤0.01% 2377
2023
Q4
$8.06K Sell
374
-431
-54% -$7.95K ﹤0.01% 1662
2023
Q3
$15K Sell
805
-95
-11% -$2.22K ﹤0.01% 1244
2023
Q2
$22.8K Hold
900
﹤0.01% 1106
2023
Q1
$23.3K Sell
900
-175
-16% -$4.68K ﹤0.01% 1018
2022
Q4
$25.4K Buy
+1,075
New +$29K ﹤0.01% 990
2022
Q1
Sell
-77
Closed -$7K 1842
2021
Q4
$7K Buy
+77
New +$9.2K ﹤0.01% 1138

Other funds holding TDOC

EverSource Wealth Advisors's TDOC Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Teladoc Health (TDOC) stake by 4.1% in Q2 2026, buying an estimated $1.54K and bringing the position to 5,889 shares worth $49.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1781.

EverSource Wealth Advisors first reported a position in TDOC in Q4 2021 and has held it in 16 quarters since. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • EverSource Wealth Advisors held 5,889 shares of Teladoc Health worth $49.9K as of Q2 2026.
  • EverSource Wealth Advisors bought 232 Teladoc Health shares in Q2 2026, an estimated $1.54K.
  • Teladoc Health made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1781 holding.
  • EverSource Wealth Advisors first reported a position in Teladoc Health in Q4 2021 and has held it in 16 quarters since.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.